Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

Notice to Readers: Opening of Nonoccupational HIV Postexposure




 

Morbidity and Mortality Weekly Report (06/18/99) Vol. 48, No.

The National Nonoccupational HIV Postexposure Prophylaxis (PEP) Registry opened for enrollment on June 7th. The purpose of the registry is to monitor episodes of potential HIV exposure due to sexual contact, intravenous drug use, and other non-occupational events. Those who enroll are not required to have received antiretroviral PEP. Those enrolled provide information regarding the type of exposure, decision to use or not use PEP, drugs taken, risk reduction referrals, and results of HIV tests; however, no identifying information, such as names, will be used. The information taken is reported nationally and used with information from other countries to monitor the use of PEP for nonoccupational HIV exposures and the clinical outcomes of PEP.



 


Copyright © 1999 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in June 18, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.